RESUMEN
50 Cases with histologically confirmed malignant tumors of the Nasopharynx were treated at the Institute of Radiology and Nuclear Medicine, Baghdad, over the period 1980-1984 inclusive/the majority of patients were in an advanced stage of the disease with cervical lymphadenopathy found in 78%. Radical Radiotherapy treatment was given in two phases with a total dose of 6500 CGY over 6-7 weeks. Combination chemotherapy in the from of Vincristine, Bleomycin and Methotrexate was given to 18 patients and five patients received cisplation combination in addition to radiotherapy. The five years survival rate was 64%. There were no statistical significant difference in the survival of those given chemotherapy in addition to radiotherapy. One patient developed radiation myelitis and died 3 years after therapy. A clear correlation between the stage of the disease and the prognosis was evident